Your browser doesn't support javascript.
loading
Subject-Controlled, On-demand, Dorsal Genital Nerve Stimulation to Treat Urgency Urinary Incontinence; a Pilot.
van Breda, Hendrikje M K; Farag, Fawzy F; Martens, Frank M J; Heesakkers, John P F A; Rijkhoff, Nico J M.
Afiliação
  • van Breda HM; Department of Urology, Radboud University Nijmegen Medical Centre Nijmegen, Netherlands.
  • Farag FF; Department of Urology, Radboud University Nijmegen Medical CentreNijmegen, Netherlands; Department of Urology, Sohag University HospitalSohag, Egypt.
  • Martens FM; Department of Urology, Radboud University Nijmegen Medical Centre Nijmegen, Netherlands.
  • Heesakkers JP; Department of Urology, Radboud University Nijmegen Medical Centre Nijmegen, Netherlands.
  • Rijkhoff NJ; Center for Sensory-Motor Interaction, Aalborg University Aalborg, Denmark.
Front Neurosci ; 10: 24, 2016.
Article em En | MEDLINE | ID: mdl-26903792
ABSTRACT

OBJECTIVES:

To evaluate the effect of subject-controlled, on-demand, dorsal genital nerve (DGN) stimulation on non-neurogenic urgency urinary incontinence (UUI) in a domestic setting. MATERIALS AND

METHODS:

Non-neurogenic patients >18 years with overactive bladder symptoms and UUI were included. Exclusion criteria were mainly stress urinary incontinence. Patients underwent 1 week of subject-controlled, on-demand, DGN stimulation, delivered by a percutaneously placed electrode near the DGN connected to an external stimulator (pulse-rate 20 Hz, pulse-width 300 µs). Patients activated the stimulator when feeling the urge to void and stimulated for 30 s. The amplitude was set at the highest tolerable level. A bladder diary including a severity score of the UUI episodes/void (scores 0 = none, 1 = drops, 2 = dashes, 3 = soaks) and a padtest was kept 3 days prior to, during, and 3 days after the test period. The subjective improvement was also scored.

RESULTS:

Seven patients (4 males/3 females) were enrolled, the mean age was 55 years (range 23-73). Six completed the test week. In the remaining patient the electrode migrated and was removed. 5/6 finalized the complete bladder diary, 1/6 recorded only the heavy incontinence episodes (score = 3). 4/6 completed the padtest. In all patients who finalized the bladder diary the number of UUI episodes decreased, in 3/5 with ≥60%. The heavy incontinence episodes (score = 3) were resolved in 2/6 patients, and improved ≥80% in the other 4. The severity score of the UUI episodes/void was improved with ≥ 60% in 3/5 patients. The mean subjective improvement was 73%.

CONCLUSION:

This feasibility study indicates that subject-controlled, on-demand DGN stimulation using a percutaneously placed electrode is possible over a longer time period, in a home setting, with a positive effect on non-neurogenic overactive bladder symptoms with UUI. Although the placement is an easy procedure, it is difficult to fixate the electrode to keep it in the correct position. Improvements in hardware, like a better fixated electrode and an easy to control stimulator, are necessary to make SODGNS a treatment possibility in the future.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Neurosci Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Neurosci Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda